How has been the historical performance of Nath Bio-Genes?

Answer:The historical performance of Nath Bio-Genes shows a consistent growth trend in net sales and profitability over the past four years.

Breakdown:
Nath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 Cr in Mar'22 to 364.91 Cr in Mar'25. The total operating income followed a similar trajectory, reflecting the same figures as net sales. The company's total expenditure, excluding depreciation, also increased from 241.18 Cr in Mar'22 to 315.11 Cr in Mar'25, driven by higher manufacturing and selling expenses. Operating profit (PBDIT) showed a positive trend, increasing from 39.03 Cr in Mar'22 to 54.35 Cr in Mar'25, although the operating profit margin slightly decreased from 13.36% to 13.65% during the same period. Profit before tax improved significantly from a loss of 63.43 Cr in Mar'22 to a profit of 40.04 Cr in Mar'25, while profit after tax also rose from a loss of 67.39 Cr to a profit of 38.06 Cr. The earnings per share (EPS) improved from -35.46 in Mar'22 to 20.32 in Mar'25, indicating a strong recovery. The cash flow from operating activities increased from 17.00 Cr in Mar'22 to 74.00 Cr in Mar'24, contributing to a closing cash and cash equivalent of 77.00 Cr in Mar'24, up from 4.00 Cr in Mar'23. Overall, Nath Bio-Genes has shown significant recovery and growth in its financial performance over the past four years.